StockData
EyePoint, Inc. logo

EyePoint, Inc. (EYPT) stock

EYPTNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.27−0.02 (-8.08%)

Close on Nov 18, 2026Market cap $23.45MP/E –Yield –

EyePoint revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

EyePoint's revenue for the twelve months ending Jun 30, 2026 was $2.79M, down 94.6% year over year. For fiscal 2025 it was $31.37M, down 27.5% from the year before. Over ten years it grew 24.6% a year on average. The highest annual figure on record is $46.02M in fiscal 2023.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$31.37M-27.5%
FY2024Dec 31, 2024$43.27M-6.0%
FY2023Dec 31, 2023$46.02M+11.1%
FY2022Dec 31, 2022$41.40M+12.1%
FY2021Dec 31, 2021$36.94M+7.3%
FY2020Dec 31, 2020$34.44M+1063.0%
FY2018Jun 30, 2018$2.96M-60.7%
FY2017Jun 30, 2017$7.54M+365.4%
FY2016Jun 30, 2016$1.62M-93.9%
FY2015Jun 30, 2015$26.57M+664.9%
FY2014Jun 30, 2014$3.47M+62.1%
FY2013Jun 30, 2013$2.14M-39.2%
FY2012Jun 30, 2012$3.53M-29.0%
FY2011Jun 30, 2011$4.97M-78.5%
FY2010Jun 30, 2010$23.05M–

Quarterly revenue

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$507.00K-90.5%
Q1 FY2026CQ1 2026Mar 31, 2026$696.00K-97.2%
Q4 FY2025CQ4 2025Dec 31, 2025$620.00K-94.6%
Q3 FY2025CQ3 2025Sep 30, 2025$966.00K-90.8%
Q2 FY2025CQ2 2025Jun 30, 2025$5.33M-43.7%
Q1 FY2025CQ1 2025Mar 31, 2025$24.45M+109.3%
Q4 FY2024CQ4 2024Dec 31, 2024$11.59M-17.4%
Q3 FY2024CQ3 2024Sep 30, 2024$10.52M-30.8%
Q2 FY2024CQ2 2024Jun 30, 2024$9.48M+4.1%
Q1 FY2024CQ1 2024Mar 31, 2024$11.68M+52.1%
Q4 FY2023CQ4 2023Dec 31, 2023$14.03M+33.2%
Q3 FY2023CQ3 2023Sep 30, 2023$15.20M+51.8%
Q2 FY2023CQ2 2023Jun 30, 2023$9.11M-21.3%
Q1 FY2023CQ1 2023Mar 31, 2023$7.68M-17.3%
Q4 FY2022CQ4 2022Dec 31, 2022$10.53M-8.8%
Q3 FY2022CQ3 2022Sep 30, 2022$10.01M+10.5%
Q2 FY2022CQ2 2022Jun 30, 2022$11.57M+28.3%
Q1 FY2022CQ1 2022Mar 31, 2022$9.29M+26.9%
Q4 FY2021CQ4 2021Dec 31, 2021$11.54M+61.9%
Q3 FY2021CQ3 2021Sep 30, 2021$9.06M-42.3%
Q2 FY2021CQ2 2021Jun 30, 2021$9.01M+118.7%
Q1 FY2021CQ1 2021Mar 31, 2021$7.32M-2.2%
Q4 FY2020CQ4 2020Dec 31, 2020$7.13M+897.3%
Q3 FY2020CQ3 2020Sep 30, 2020$15.70M+1591.3%
Q2 FY2020CQ2 2020Jun 30, 2020$4.12M+341.8%
Q1 FY2020CQ1 2020Mar 31, 2020$7.49M+1845.2%
Q4 FY2018CQ2 2018Jun 30, 2018$715.00K+2.0%
Q3 FY2018CQ1 2018Mar 31, 2018$928.00K+57.3%
Q2 FY2018CQ4 2017Dec 31, 2017$933.00K-84.4%
Q1 FY2018CQ3 2017Sep 30, 2017$385.00K+39.0%
Q4 FY2017CQ2 2017Jun 30, 2017$701.00K+130.6%
Q3 FY2017CQ1 2017Mar 31, 2017$590.00K+82.1%
Q2 FY2017CQ4 2016Dec 31, 2016$5.97M+1035.2%
Q1 FY2017CQ3 2016Sep 30, 2016$277.00K-40.6%
Q4 FY2016CQ2 2016Jun 30, 2016$304.00K-25.7%
Q3 FY2016CQ1 2016Mar 31, 2016$324.00K-1.2%
Q2 FY2016CQ4 2015Dec 31, 2015$526.00K–
Q1 FY2016CQ3 2015Sep 30, 2015$466.00K–
Q4 FY2015CQ2 2015Jun 30, 2015$409.00K–
Q3 FY2015CQ1 2015Mar 31, 2015$328.00K–

More EyePoint figures

See a number that looks wrong?